Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma.
D000328:Adult; D001772:Blood Cell Count; D002277:Carcinoma / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007275:Injections, Intravenous; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D013997:Time Factors
D003520:Cyclophosphamide; D008558:Melphalan